ArticleCancer discovery2025

Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Yi-Jiun Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.